Loading chat...
NY A01017
Bill
Status
2/14/2025
Primary Sponsor
Amy Paulin
Click for details
AI Summary
-
Amends the public health law to expand the drug-induced movement disorder screening education program established in 2024
-
Requires educational materials to address screening, symptom identification, treatment options, and methods to reduce stigma experienced by people with drug-induced movement disorders related to mental health treatment
-
Mandates that educational materials for healthcare providers be developed in consultation with the Commissioner of the Office of Mental Health
-
Requires dissemination of materials in coordination with relevant healthcare provider groups, incorporating best practices from the American Psychiatric Association and other professional society guidelines
-
Takes effect on the same date as the 2024 law establishing the original drug-induced movement disorder screening education program (S. 8965-A/A. 6799-B)
Legislative Description
Provides for education and outreach for drug-induced movement disorders by the department of health through the health care and wellness education and outreach program.
Last Action
signed chap.37
2/14/2025